This is a routine procedural filing with no material impact. Traders should note that all Part III information is now available and no further proxy statement incorporation is needed. Monitor the upcoming proxy statement for any potential changes to compensation or governance that were not included in this amendment.
Price Chart
Executive Summary
Arcellx filed an amended 10-K/A to include Part III disclosures (director and executive compensation, ownership, and related-party transactions) that were omitted from its original 10-K and would have otherwise been incorporated by reference from a future proxy statement. The amendment also includes required CEO and CFO certifications. No financial data or other disclosures were revised. This is a routine procedural filing.
Key Facts
- The 10-K/A is an amendment to include Part III disclosures (Items 10-14) that were omitted from the original 10-K filing.
- The original filing relied on General Instruction G(3) to incorporate Part III by reference from a future proxy statement, but the company chose to file the information directly via this amendment.
- No financial statements, results, or other disclosures from the original 10-K were changed or updated.
- The filing includes required Rule 13a-14(a) certifications from the CEO and CFO.
- The amendment is purely procedural and does not reflect any changes in the company's financial condition, operations, or governance.
Financial Impact
No financial impact. This is a disclosure-only amendment.
Risk Factors
- None related to this filing. The amendment itself carries no risk.
- General biotech risks include clinical trial outcomes for anito-cel and integration risks related to the pending acquisition by Gilead.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001193125-26-177460 |
| Document: d332400dex311.htm | 0001193125-26-177460 |
| Document: d332400dex312.htm | 0001193125-26-177460 |
| Document: 0001193125-26-177460-index-headers.html | 0001193125-26-177460 |
| Document: 0001193125-26-177460-index.html | 0001193125-26-177460 |
| Document: 0001193125-26-177460.txt | 0001193125-26-177460 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 28, 2026 22w ago | 25-NSE | $115.07 $115.07 | · 0.00% | ▼ −0.01% | — |
Apr 24, 2026 23w ago | 10-K/A | $115.07 $115.07 | · 0.00% | ▲ +0.49% | — |
Feb 25, 2026 31w ago | Insider Cluster | $113.76 $113.88 | ▼ −0.11% | ▼ −0.65% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access